News | August 30, 2025
Lilly's Verzenio scores first OS improvement in breast Cancer
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
Subscribe To Our Newsletter & Stay Updated
